1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. AXCELLA HEALTH INC

Axcella Health Inc

XNAS: AXLA

Watchlist

Portfolio

Share


Insider Trading disclosures for Axcella Health Inc

The latest disclosure was made by Margaret Koziel in Axcella Health Inc where a trade of 679 Common Stock done at an average price of $0.6 was reported to US exchanges on March 1, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Margaret Koziel Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.58 per share. 01 Mar 2023 679 24,883 (0%) 0% 0.6 394 Common Stock
William R. Hinshaw Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 275,000 275,000 - - Stock Option (Right to Buy)
Paul Fehlner SVP & Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 70,000 70,000 - - Stock Option (Right to Buy)
Margaret Koziel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 70,000 70,000 - - Stock Option (Right to Buy)
Paul Fehlner SVP & Chief Legal Officer Sale of securities on an exchange or to another person at price $ 0.66 per share. 10 Feb 2023 5,221 58,081 (0%) 0% 0.7 3,447 Common Stock
William R. Hinshaw Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.56 per share. 17 Oct 2022 16,000 82,012 (0%) 0% 1.6 25,027 Common Stock
William R. Hinshaw Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2022 50,000 98,012 (0%) 0% - Common Stock
Margaret Koziel Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.52 per share. 06 Sep 2022 547 25,562 (0%) 0% 2.5 1,378 Common Stock
Margaret Koziel Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.01 per share. 01 Jun 2022 590 26,109 (0%) 0% 2.0 1,186 Common Stock
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 47,059 209,756 (0%) 0% 0 Common Stock
Paul J. Sekhri Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 40,000 40,000 - - Stock Option (Right to Buy)
Michael Rosenblatt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 40,000 40,000 - - Stock Option (Right to Buy)
William D. Baird Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 20,000 20,000 - - Stock Option (Right to Buy)
Catherine A. Sohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 20,000 20,000 - - Stock Option (Right to Buy)
Gary P. Pisano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 20,000 20,000 - - Stock Option (Right to Buy)
Cristina M. Rondinone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 20,000 20,000 - - Stock Option (Right to Buy)
Martin Hendrix Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 40,000 40,000 - - Stock Option (Right to Buy)
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Mar 2022 1,535 0 - - Restricted Stock Units
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2022 50,000 50,000 - - Stock Option (Right to Buy)
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Mar 2022 1,535 162,697 (0%) 0% - Common Stock
David R. Epstein Director Purchase of securities on an exchange or from another person at price $ 1.91 per share. 16 Mar 2022 26,178 161,162 (0%) 0% 1.9 50,000 Common Stock
Robert Crane Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2022 125,000 125,000 - - Stock Option (Right to Buy)
Robert Crane Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.91 per share. 16 Mar 2022 39,267 39,267 (0%) 0% 1.9 75,000 Common Stock
William R. Hinshaw Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.91 per share. 16 Mar 2022 13,089 48,012 (0%) 0% 1.9 25,000 Common Stock
Paul Fehlner SVP & Chief Legal Officer Purchase of securities on an exchange or from another person at price $ 1.91 per share. 16 Mar 2022 10,471 20,802 (0%) 0% 1.9 20,000 Common Stock
Margaret Koziel Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.86 per share. 01 Mar 2022 553 26,699 (0%) 0% 1.9 1,030 Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 1,534 134,984 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 1,534 1,535 - - Restricted Stock Units
William R. Hinshaw Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2022 275,000 275,000 - - Stock Option (Right to Buy)
William R. Hinshaw Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2022 100,000 100,000 - - Stock Option (Right to Buy)
Paul Fehlner SVP & Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2022 70,000 70,000 - - Stock Option (Right to Buy)
Alison D. Schecter President - Research & Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2022 56,000 56,000 - - Stock Option (Right to Buy)
Virginia R. Dean SVP, Chief People Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2022 71,400 71,400 - - Stock Option (Right to Buy)
Margaret Koziel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2022 33,397 33,397 - - Stock Option (Right to Buy)
William R. Hinshaw Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.65 per share. 28 Jan 2022 16,590 33,410 (0%) 0% 1.7 27,393 Common Stock
William R. Hinshaw Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jan 2022 50,000 0 - - Restricted Stock Units
William R. Hinshaw Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jan 2022 50,000 50,000 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2022 1,535 3,069 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2022 1,535 133,450 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2021 1,535 4,604 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2021 1,535 131,915 (0%) 0% - Common Stock
Alison D. Schecter President - Research & Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 25,000 25,000 - - Stock Option (Right to Buy)
Margaret Koziel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 75,000 75,000 - - Stock Option (Right to Buy)
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Nov 2021 1,534 6,139 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Nov 2021 1,534 130,380 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Oct 2021 1,535 7,673 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Oct 2021 1,535 128,846 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Sep 2021 1,535 9,208 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Sep 2021 1,535 127,311 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2021 1,534 10,743 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2021 1,534 125,776 (0%) 0% - Common Stock
Gary P. Pisano Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.28 per share. 13 Aug 2021 81,433 81,433 (0%) 0% 0.3 22,801 Common Stock
Gary P. Pisano Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Aug 2021 81,433 0 - - Stock Option (Right to Buy)
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2021 1,535 124,242 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2021 1,535 12,277 - - Restricted Stock Units
Virginia R. Dean SVP, Chief People Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2021 140,000 140,000 - - Stock Option (Right to Buy)
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2021 1,535 122,707 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2021 1,535 13,812 - - Restricted Stock Units
William D. Baird Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
Catherine A. Sohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
Gary P. Pisano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
Stephen Hoge Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
Cristina M. Rondinone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
Shreeram Aradhye Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2021 1,534 15,347 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2021 1,534 121,172 (0%) 0% - Common Stock
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2021 1,535 16,881 - - Restricted Stock Units
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2021 1,535 119,638 (0%) 0% - Common Stock
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 120,000 120,000 - - Stock Option (Right to Buy)
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 18,416 18,416 - - Restricted Stock Units
Alison D. Schecter President - Research & Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2021 250,000 250,000 - - Stock Option (Right to Buy)
Laurent Chardonnet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.60 per share. 09 Feb 2021 2,601 6,266 (0%) 0% 3.6 9,364 Common Stock
Laurent Chardonnet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2021 25,000 25,000 - - Stock Option (Right to Buy)
Laurent Chardonnet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2021 120,000 120,000 - - Stock Option (Right to Buy)
Laurent Chardonnet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2021 60,000 60,000 - - Restricted Stock Units
William R. Hinshaw Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2021 375,000 375,000 - - Stock Option (Right to Buy)
Manu Chakravarthy SVP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2021 102,000 102,000 - - Stock Option (Right to Buy)
Paul Fehlner SVP and Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2021 85,000 85,000 - - Stock Option (Right to Buy)
Paul Fehlner SVP and Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2021 42,500 42,500 - - Restricted Stock Units
Manu Chakravarthy SVP & Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2021 60,000 60,000 (0%) 0% - Common Stock
Manu Chakravarthy SVP & Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2021 60,000 60,000 - - Restricted Stock Units
Manu Chakravarthy SVP & Chief Medical Officer Sale of securities on an exchange or to another person at price $ 5.50 per share. 01 Feb 2021 18,472 41,528 (0%) 0% 5.5 101,631 Common Stock
William R. Hinshaw Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 50,000 50,000 - - Restricted Stock Units
Paul Fehlner SVP and Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2020 30,000 30,000 - - Stock Option (Right to Buy)
Shreeram Aradhye Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2020 22,000 22,000 - - Stock Option (Right to Buy)
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2020 6,800 6,800 - - Stock Option (Right to Buy)
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 65,000 65,000 - - Stock Option (Right to Buy)
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 35,000 35,000 - - Stock Option (Right to Buy)
William D. Baird Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 11,000 11,000 - - Stock Option (Right to Buy)
Catherine A. Sohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 11,000 11,000 - - Stock Option (Right to Buy)
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 11,000 11,000 - - Stock Option (Right to Buy)
Gary P. Pisano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 11,000 11,000 - - Stock Option (Right to Buy)
Stephen Hoge Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 11,000 11,000 - - Stock Option (Right to Buy)
Cristina M. Rondinone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 11,000 11,000 - - Stock Option (Right to Buy)
David R. Epstein Director Purchase of securities on an exchange or from another person at price $ 4.75 per share. 18 May 2020 50,000 118,103 (0%) 0% 4.8 237,500 Common Stock
David R. Epstein Director Purchase of securities on an exchange or from another person at price $ 3.65 per share. 27 Feb 2020 12,800 66,098 (0%) 0% 3.7 46,720 Common Stock
David R. Epstein Director Purchase of securities on an exchange or from another person at price $ 3.75 per share. 27 Feb 2020 2,005 68,103 (0%) 0% 3.8 7,519 Common Stock
Laurent Chardonnet Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.94 per share. 31 Jan 2020 3,000 3,665 (0%) 0% 4.9 14,820 Common Stock
Laurent Chardonnet Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.92 per share. 24 Jan 2020 313 313 (0%) 0% 4.9 1,540 Common Stock
Laurent Chardonnet Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.94 per share. 24 Jan 2020 352 665 (0%) 0% 4.9 1,739 Common Stock
Catherine A. Sohn Director Purchase of securities on an exchange or from another person at price $ 4.87 per share. 17 Jan 2020 1,000 1,000 (0%) 0% 4.9 4,870 Common Stock
William R. Hinshaw Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 156,700 156,700 - - Stock Option (Right to Buy)
Laurent Chardonnet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 72,500 72,500 - - Stock Option (Right to Buy)
Stephen Mitchener SVP & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 43,000 43,000 - - Stock Option (Right to Buy)
Manu Chakravarthy SVP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 41,000 41,000 - - Stock Option (Right to Buy)
Tony Tramontin SVP & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 45,000 45,000 - - Stock Option (Right to Buy)
Paul Fehlner SVP & Chief IP Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 18,000 18,000 - - Stock Option (Right to Buy)
Shreeram Aradhye EVP & Chief Developmnt Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 54,500 54,500 - - Stock Option (Right to Buy)
Shreeram Aradhye EVP & Chief Developmnt Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 66,801 66,801 - - Restricted Stock Units
Heidy King-Jones General Counsel, SVP Legal Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 35,000 35,000 - - Stock Option (Right to Buy)
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 3.91 per share. 26 Nov 2019 1,005 53,298 (0%) 0% 3.9 3,930 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 3.91 per share. 26 Nov 2019 1,005 53,298 (0%) 0% 3.9 3,930 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 3.55 per share. 26 Nov 2019 14,000 52,293 (0%) 0% 3.6 49,700 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 3.55 per share. 26 Nov 2019 14,000 52,293 (0%) 0% 3.6 49,700 Common Stock
David R. Epstein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2019 65,000 65,000 - - Stock Option (Right to Buy)
David R. Epstein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2019 35,000 35,000 - - Stock Option (Right to Buy)
Catherine A. Sohn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2019 22,000 22,000 - - Stock Option (Right to Buy)
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 6.98 per share. 01 Aug 2019 4,092 35,444 (0%) 0% 7.0 28,562 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 7.04 per share. 01 Aug 2019 2,849 38,293 (0%) 0% 7.0 20,057 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 7.55 per share. 17 Jul 2019 1,000 31,352 (0%) 0% 7.6 7,550 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 8.24 per share. 08 Jul 2019 4,200 29,030 (0%) 0% 8.2 34,608 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 8.07 per share. 08 Jul 2019 1,322 30,352 (0%) 0% 8.1 10,669 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 9.00 per share. 08 Jul 2019 274 24,830 (0%) 0% 9 2,466 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 8.77 per share. 01 Jul 2019 3,500 19,000 (0%) 0% 8.8 30,678 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 8.98 per share. 01 Jul 2019 56 19,056 (0%) 0% 9.0 503 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 8.74 per share. 01 Jul 2019 1,000 15,500 (0%) 0% 8.7 8,735 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 10.04 per share. 27 Jun 2019 5,400 20,000 (0%) 0% 10.0 54,216 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 9.15 per share. 27 Jun 2019 100 14,600 (0%) 0% 9.2 915 Common Stock
David R. Epstein None Purchase of securities on an exchange or from another person at price $ 9.57 per share. 26 Jun 2019 14,500 14,500 (0%) 0% 9.6 138,765 Common Stock
David R. Epstein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2019 11,000 11,000 - - Stock Option (Right to Buy)
William D. Baird None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2019 11,000 11,000 - - Stock Option (Right to Buy)
Gregory Behar None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2019 11,000 11,000 - - Stock Option (Right to Buy)
Gary P. Pisano None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2019 11,000 11,000 - - Stock Option (Right to Buy)
Stephen Hoge None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2019 11,000 11,000 - - Stock Option (Right to Buy)
Cristina M. Rondinone None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2019 11,000 11,000 - - Stock Option (Right to Buy)
William R. Hinshaw Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2019 60,803 60,803 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters